MedTrace Logo

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

NCT03856372 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1494

Last updated 2019-02-27

No results posted yet for this study

Summary

The study was designed to investigate whether hypofractionated adjuvant radiotherapy is noninferior to conventionally fractionated adjuvant radiotherapy in terms of efficacy and toxicities for high risk breast cancer patients treated with mastectomy

Conditions

Interventions

RADIATION

Hypofractionated

daily fractions, five fractions per week.

RADIATION

Conventional

daily fractions, five fractions per week.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Jinli Ma, MD, PhD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2023-09-30
Completion
2028-10-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03856372 on ClinicalTrials.gov